Correlation Between Nanomix and Abbott Laboratories
Can any of the company-specific risk be diversified away by investing in both Nanomix and Abbott Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanomix and Abbott Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanomix and Abbott Laboratories, you can compare the effects of market volatilities on Nanomix and Abbott Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanomix with a short position of Abbott Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanomix and Abbott Laboratories.
Diversification Opportunities for Nanomix and Abbott Laboratories
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Nanomix and Abbott is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Nanomix and Abbott Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abbott Laboratories and Nanomix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanomix are associated (or correlated) with Abbott Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abbott Laboratories has no effect on the direction of Nanomix i.e., Nanomix and Abbott Laboratories go up and down completely randomly.
Pair Corralation between Nanomix and Abbott Laboratories
If you would invest 0.02 in Nanomix on September 13, 2024 and sell it today you would earn a total of 0.00 from holding Nanomix or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.45% |
Values | Daily Returns |
Nanomix vs. Abbott Laboratories
Performance |
Timeline |
Nanomix |
Abbott Laboratories |
Nanomix and Abbott Laboratories Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nanomix and Abbott Laboratories
The main advantage of trading using opposite Nanomix and Abbott Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanomix position performs unexpectedly, Abbott Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will offset losses from the drop in Abbott Laboratories' long position.Nanomix vs. Anteris Technologies | Nanomix vs. Armm Inc | Nanomix vs. Cellink AB | Nanomix vs. Bone Biologics Corp |
Abbott Laboratories vs. AbbVie Inc | Abbott Laboratories vs. Eli Lilly and | Abbott Laboratories vs. Bristol Myers Squibb | Abbott Laboratories vs. Johnson Johnson |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |